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Abstract 
Background: Kikuchi–Fujimoto disease is so named because Kikuchi and Fujimoto were the first scientists to 
describe it in Japan in 1972. Although the disease has been reported from all over the world and more so from 
Asia, it is rare. To date only eight cases have been reported from Nepal. Cervical lymphadenopathy, fever and raised 
Erythrocyte Sedimentation Rate are usual presenting features of this disease. We describe a case which presented 
with thrombocytopenia and axillary lymphadenopathy in addition to the usual features. Out of the total eight cases 
that have been reported from Nepal so far, no patients had thrombocytopenia and only one patient had axillary 
lymphadenopathy.
Case presentation: A 24-year-old Nepali female presented with a 3-week history of low-grade fever, headache, 
and painful, discrete, unilateral left-sided cervical and axillary lymphadenopathy. Among the multitude of tests that 
were carried out, Erythrocyte Sedimentation Rate was raised and there was thrombocytopenia while other tests 
were normal. Painful lymphadenopathy pointed to bacterial lymphadenitis while chronic low-grade fever suggested 
tuberculosis. A cervical lymph node was excised for histopathological examination to reach an accurate diagnosis. On 
the basis of pathognomonic features viz., paracortical foci composed of various types of histiocytes including cres-
centic type in the background of abundant apoptotic karyorrhectic debris, a diagnosis of Kikuchi–Fujimoto disease 
was made. On follow-up evaluation after 6 weeks, the patient had no systemic symptoms, enlarged lymph nodes had 
regressed in size significantly, and Erythrocyte Sedimentation Rate and platelet count had become normal.
Conclusion: Kikuchi–Fujimoto disease should be kept in the differential diagnosis of lymphadenopathy in young 
patients, female or male even in tuberculosis-endemic countries and even in patients who have unusual features; for 
example thrombocytopenia and involvement of axillary lymph nodes in addition to cervical lymph nodes as in this 
case.
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Background
Kikuchi–Fujimoto disease (KFD), also known as histio-
cytic necrotizing lymphadenitis, was first described inde-
pendently by two Japanese scientists, Dr. Kikuchi and 
Dr. Fujimoto in the same year, 1972. The disease process 
subsides within 1–4  months without specific treatment 
[1]. The exact cause of the disease is not known, although 
the viral etiology is suspected [2]. KFD is a rare disease 
having world-wide distribution, but it is more common 
in Asia. The disease is more common in young females 
than males. Most of the patients present with unilateral, 
painful or painless cervical lymphadenopathy and fever. 
Axillary and inguinal lymph nodes are less frequently 
involved. Diagnosis of KFD is achieved by histopathologi-
cal examination of affected lymph nodes [1]. There are no 
laboratory findings specific to KFD. Anemia, elevation of 
ESR and mild leukopenia may be found in some patients 
[3]. Thrombocytopenia is a rare finding [4].
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Clinical presentation of low-grade fever with lym-
phadenopathy can cause confusion with tuberculosis, 
toxoplasmosis and infectious mononucleosis [5]. Non-
Hodgkin’s lymphoma comes in the list of differential 
diagnoses, especially when there are atypical immunob-
lasts [6].
To date only eight cases have been reported from Nepal 
[7–9]. In the patient of this case report, two uncommon 
findings were present along with other usual findings viz., 
thrombocytopenia and combined cervical plus axillary 
lymphadenopathy.
Case presentation
Present case deals with a 24-year-old Nepali female 
patient who presented with a 3-week history of low-
grade fever, fatigue, headache, and lymphadenopathy. She 
reported no weight loss, night sweats and anorexia. The 
patient did not have a history of tuberculosis and other 
significant illnesses in the past. The patient complained 
of painful unilateral left-sided cervical and axillary lym-
phadenopathy. Enlarged lymph nodes were found to be 
tender and discrete. Largest lymph node was in the cervi-
cal region which measured 3 × 3 cm.
Laboratory investigations for complete blood count, 
Erythrocyte Sedimentation Rate (ESR), liver function 
tests, renal function tests, anti-nuclear antibody and 
rheumatoid arthritis factor were performed. ESR as 
measured by Westergren method was 64 mm/h (normal 
range: <20 mm/h in females). Platelet count was 120,000/
µl (normal range: 150,000–450,000/µl). Other test find-
ings were within normal limits, including hemoglobin 
and total and differential leukocyte count.
There was a dilemma in clinical diagnosis because lym-
phadenopathy was painful, but the patient had raised ESR 
and low-grade fever. Painful lymphadenopathy pointed to 
reactive (bacterial) lymphadenitis while increased ESR 
and low-grade fever pointed to tuberculosis. Therefore 
empirical treatment was started with a 1-week’s course of 
broad-spectrum antibiotic. But the patient did not show 
any improvement and therefore cervical lymph node was 
excised for histopathological examination.
Low power microscopic examination of section pre-
pared from affected lymph node showed discrete 
necrotic area. Pathognomonic features of KFD were seen 
on higher power microscopic examination viz., paracor-
tical foci composed of small to large lymphocytes, plas-
macytoid monocytes and various types of histiocytes 
(Fig.  1) including crescentic type (Fig.  2) in the back-
ground of apoptotic bodies and abundant karyorrhectic 
debris (Fig.  1). Ghost cell represented complete karyor-
rhexis (Fig. 2). Neutrophils, eosinophils and plasma cells 
were conspicuous by their absence. Lymphocytes did 
not show atypia. Mitotic figures were not present. There 
were no granulomas. Microscopic features of lupus lym-
phadenopathy viz., follicular hyperplasia with interfolli-
cular immunoblasts and Reed-Sternberg-like giant cells 
and paracortical necrosis with hematoxylin bodies were 
absent. On the basis of these histopathological findings, 
a diagnosis of Kikuchi–Fujimoto disease (histiocytic 
necrotizing lymphadenitis) was made. Immunohisto-
chemical analysis was not done on the sections because 
of confirmed diagnosis on the basis of light microscopic 
examination of Hematoxylin and Eosin stained sections.
Follow‑up visit
During the evaluation after 6 weeks, the patient reported 
no systemic symptoms and her lymph nodes had 
regressed in size significantly and ESR and platelet count 
were restored to normal range, without any treatment.
Discussion
Epidemiology
Although uncommon, KFD has been described from all 
over the world [10]. Most cases have been reported from 
Fig. 1 High power view showing apoptotic bodies (arrow heads) and 
histiocytes (arrows). H&E ×40 objective
Fig. 2 High power view showing ghost cell (arrow head) and cres-
centic histiocyte (arrow). H&E ×40 objective
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Asia [1]. However, only eight cases have been reported 
from Nepal, a country in Asia.
Lymph nodes affected
Cervical lymph nodes have been found to be affected in 
nearly all the patients in previous studies. Cervical lymph 
nodes were affected in seven and axillary lymph nodes 
in only one out of the eight cases reported from Nepal 
[7–9]. In the 11 cases reported from India, involvement 
of cervical lymph nodes was 100 %. Only one patient had 
generalized lymphadenopathy [5, 11–16]. In a retrospec-
tive study of 195 patients by Cheng et  al., only 2.6 % of 
patients had axillary lymphadenopathy [17]. These stud-
ies indicate that the involvement of axillary lymph nodes 
is not common in KFD.
Laboratory findings
Although no laboratory finding is specific for KFD, leu-
kopenia and raised ESR may be present. Leukopenia 
was present in 31.3 % patients in a study of 96 cases by 
Kwon et al. [18]. Raised ESR was found in all patients in 
a study of six cases by Adhikari et al. [7]. Among the six 
patients reported from India, raised ESR was observed in 
five cases, and leukopenia and leukocytosis were found 
in one patient each [5, 11, 13–16]. Thrombocytopenia is 
rare. It was not present in any of the eight cases reported 
previously from Nepal [7–9]. In the study by Cheng et al., 
leukopenia, leukocytosis and thrombocytopenia were 
present in 18.9, 1.4 and 5.4  % of patients, respectively 
[17].
Differential diagnoses
Because most of the patients of KFD present with local-
ized lymphadenopathy and low-grade fever, it mimics 
tuberculosis clinically; this is particularly true in coun-
tries where tuberculosis is endemic, for example Nepal 
and other South Asian countries [1, 19]. Tuberculosis is 
so common in Nepal that it is the number one provisional 
diagnosis for any longstanding nontender lymphade-
nopathy. In this case report, although lymphadenopathy 
was longstanding it was painful too. Therefore, bacterial 
lymphadenitis was number one provisional clinical diag-
nosis followed by tuberculosis. This case gives a lesson 
to keep KFD as one of the potential diagnoses even in 
countries where tuberculosis is endemic. There are some 
more diseases which come in the differential diagnosis of 
KFD viz., non-Hodgkin lymphoma, systemic lupus ery-
thematosus, infectious mononucleosis, toxoplasmosis 
and cat scratch disease. Although fine needle aspiration 
cytology (FNAC) is less invasive and cheaper, and turna-
round time for diagnosis is shorter, its accuracy is only 
56  %. Nevertheless, in the presence of clear-cut clinical 
findings, a diagnosis of KFD can be made by FNAC if 
unequivocal cytological features are present. But when 
unusual clinical features are present as in this case, his-
topathological evaluation of affected lymph nodes is the 
preferred diagnostic method [1, 10]. KFD has been classi-
fied histopathologically into three evolving phases: prolif-
erative, necrotizing and xanthomatous. The first phase is 
characterized by the presence of histiocytes and plasma-
cytoid monocytes in the background of apoptotic kary-
orrhectic debris. Our case has histopathological features 
of this phase. In necrotizing phase, coagulative necrosis 
is also present and in xanthomatous phase, foamy histio-
cytes predominate [10].
Conclusion
Kikuchi–Fujimoto disease should be kept in the differ-
ential diagnosis of lymphadenopathy in young patients, 
female or male even in tuberculosis-endemic countries 
and even in patients who have unusual features; for 
example thrombocytopenia and involvement of axillary 
lymph nodes in addition to cervical lymph nodes as in 
this case.
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